Actively Recruiting
Environmental Factors Associated With Peripheral Neuropathies in French Guiana
Led by Admin CIC · Updated on 2026-01-15
78
Participants Needed
2
Research Sites
81 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Peripheral neuropathies (PN) affect 1% of the global population, particularly the elderly. About 20-30% of cases remain unexplained. In French Guiana, we hypothesize that factors like neurotoxic traditional plant remedies, arboviral disease outbreaks, and mercury exposure from illegal gold mining may contribute to PN. The study aims to assess the association between PN and exposure to arboviral infections, heavy metals, and plant consumption in French Guiana.
CONDITIONS
Official Title
Environmental Factors Associated With Peripheral Neuropathies in French Guiana
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy (Case group)
- Patients hospitalized or consulting at hospitals in Cayenne and Saint-Laurent du Maroni without peripheral neuropathy (Control group)
- Age 18 years or older
You will not qualify if you...
- Patients under the age of 18
- Patients who object to participation
- Patients unable to complete the questionnaire
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Centre Hospitalier de Cayenne
Cayenne, French Guiana, 97300
Actively Recruiting
2
Centre Hospitalier de l'Ouest Guyanais
Saint-Laurent-du-Maroni, French Guiana, 97320
Actively Recruiting
Research Team
N
Nathalie DESCHAMPS, Principal Investigator
CONTACT
V
Vincent De Paul SENEKIAN, Principal Investigator
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here